Strand Therapeutics
Drug DiscoveryWebsite
Developer of a medicine infrastructure platform intended to create medicines that respond to disease signals in real-time. The company's platform helps create programmable messenger ribonucleic acid t...
Valuation
$571M
Market implied
Share Price
N/A
Total Raised
$255.6M
Last Round
Later Stage VC (Series B)
Aug 2025
Latest Funding Round
Later Stage VC (Series B)
Aug 7, 2025
$153M
raised
Investors
+29 other investors